Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
IVERMECTIN
Cross Vetpharm Group Limited
QP54AA01
IVERMECTIN
1.0 %w/v
Solution for Injection
LM-Licensed Merchant
Bovine
Ivermectin
Endectoparasiticides
Authorised
2001-06-05
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Bovimectin 1 % solution for injection for cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active Substance Ivermectin 1.0 % w/v (10 mg/ml) For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for injection. A clear colourless solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (Beef and non lactating cattle) The veterinary medicinal product can be given to all ages of animals including young calves. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 30/11/2015_ _CRN 7022356_ _page number: 1_ 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The veterinary medicinal product is indicated for the effective treatment and control of the following harmful parasites of cattle: GASTRO-INTESTINAL ROUNDWORMS: _Ostertagia _spp. (including inhibited _O. ostertagi) _(adult and fourth stage larvae) _Haemonchus placei _(adult and fourth stage larvae) _Trichostrongylus spp. _(adult and fourth stage larvae) _Cooperia _spp. (adult and fourth stage larvae) _Nematodirus spp. _(adult) LUNGWORMS: _Dictyocaulus viviparus _(adult and fourth stage larvae) WARBLES (parasitic stages): _Hypoderma spp._ MANGE MITES: _Psoroptes bovis_ _Sarcoptes scabiei _var. _bovis._ SUCKING LICE: _Linognathus vituli_ _Haematopinus eurysternus_ PERSISTENT ACTIVITY Treatment at the recommended dose rate controls re-infection with _Haemonchus placei _and _Cooperia _spp. acquired up to 14 days after treatment, _Ostertagia ostertagi _acquired up to 21 days after treatment and _Dictyocaulus viviparus _acquired up to 28 days after treatment. To obtain optimal benefit from the persistent activity of the veterinary medicinal product for grazing ani Citiți documentul complet